Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Aspirin Market From 2025 to 2029?

Over the past years, the market size for aspirin has been experiencing consistent growth. It is projected to expand from $2.56 billion in 2024 to $2.66 billion in 2025, with a compound annual growth rate (CAGR) of 3.7%. The increment in the historic phase can be credited to the requirement for pain management and analgesics, heightened awareness for cardiovascular health, its anti-inflammatory features, precautions against strokes and cardiac arrests, as well as the treatment of ailments such as fever, headaches, rheumatic fever, and arthritis.

In the coming years, the aspirin market is projected to witness significant growth. The market is predicted to expand to “$3.31 billion by 2029, with a compound annual growth rate (CAGR) of 5.7%.” The projected growth during the forecast period can be accredited to factors such as a surge in the prevalence of chronic diseases, aspirin’s potential benefits for neurological conditions, innovation in the pharmaceutical sector, increased uptake in emerging areas, and the rising trend of self-care practices. Major forecasts for this period include research on cancer prevention, combination treatments, personalized medicine strategies, customised dosage forms and delivery systems, telemedicine, and self-care.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9154&type=smp

What Elements Are Contributing To Growth In The Aspirin Market?

The escalating incidence of arthritis is predicted to fuel the aspirin market’s expansion in the future. This medical disorder, marked by joint pain and inflammation, has seen a rise in cases. Aspirin, a nonsteroidal anti-inflammatory drug, is beneficial for sufferers of chronic pain from arthritis and other similar conditions, as it alleviates inflammation, minimizes pain, and enhances physical functionality. Consequently, an upswing in arthritis patients translates into a greater consumption of aspirin. To illustrate, data from the Health and Safety Executive (HSE), a UK government agency, in November 2023, pointed to a total of 473,000 workers affected by work-related musculoskeletal disorders during 2022-2023, a prevalence rate that translates to 1,400 per 100,000 workers. Furthermore, new instances totalled 132,000, indicating an incidence rate of 390 per 100,000 workers. This growing incidence of arthritis is therefore a major factor contributing to the expansion of the aspirin market.

Which Segments Are Detailed In The Global Aspirin Market Report?

The aspirin market covered in this report is segmented –

1) By Product: Prescription, OTC

2) By Route Of Administration: Oral, Rectal, Parenteral

3) By Dosage Form: Tablets, Capsules, Injections, Suppositories

4) By Application: Cardiovascular Disease, Pain, Fever, O Inflammation, Other Applications

5) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Prescription Aspirin: Low-Dose Aspirin (81 Mg), High-Dose Aspirin (325 Mg)

2) By OTC (Over-the-Counter) Aspirin: Regular Strength Aspirin (325 Mg), Extra-Strength Aspirin (500 Mg), Buffered Aspirin, Aspirin Combinations

Which Trends Are Redefining The Future Landscape Of The Aspirin Industry?

Major firms active in the aspirin market are pursuing strategic partnerships to augment technology integration and broaden their market footprint. Such partnerships usually involve a synergistic relationship where two or more entities pool their resources, capabilities, and endeavors to accomplish shared targets or goals. An instance of this was in February 2023, when Huma Therapeutics Limited (‘Huma’), a digital health firm based in the UK, allied with Bayer AG, a life sciences firm based in Germany. This partnership aimed to launch the Bayer Aspirin Heart Risk Assessment online tool, designed to help users determine their potential risk factors for cardiovascular disease over the next ten years and enable them to discuss the results with their physician. Huma has formulated an algorithm that forecasts long-term cardiovascular disease risk based on data from the UK Biobank. The Heart Risk Assessment tool is available at Bayer Aspirin, featuring an intuitive 15-question questionnaire. Depending on their answers, the tool evaluates if they are at a high, average, or low risk of developing cardiovascular disease by contrasting their responses with those gathered from the research population.

Who Are The Key Contributors To Growth In The Aspirin Market?

Major companies operating in the aspirin market include Bayer AG, Allegiant Health, Par Pharmaceutical, Cardinal Health Inc., Nanjing pharmaceutical factory Co. Ltd., JQC (Huayin) Pharmaceutical Co. Ltd., LNK International Inc., Bal Pharma Limited, Trumac Healthcare, Perrigo Company PLC, Alta Laboratories Ltd., Zhenjiang Gaopeng Pharmaceutical Co. Ltd., J.M. Loveridge Ltd., Mayne Pharma Group Limited, St. Joseph’s Aspirin, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, Hetero Labs Ltd., Jubilant Generics Ltd., Lupin Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/aspirin-global-market-report

Which Region Is Projected To Lead The Aspirin Market By 2025?

Asia-Pacific was the largest region in the aspirin market in 2024. The regions covered in the aspirin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9154&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model